In non-GCB DLBCL, CK1α-dependent constitutive activation of the NFκB pathway has been observed, implying that the interaction between CK1α and the CBM complex is indispensable in this tumor type (19, 36, 37). The gene discussed is CSNK1A1; the disease is diffuse large B-cell lymphoma.